Clinical trial Recruiting at 1 site Interventional Ages 6 to 13

Targeted Lens Intervention for Anisometropia in Children

Official title: Clinical Investigation of Targeted Lens Intervention in the Management of Myopic Anisometropia in Children

Run by Essilor International · NCT07533149 · Data updated 2026-11-12

We’re testing if research spectacles can reduce the difference in prescription between a child’s eyes when one eye is more myopic than the other.

Quick facts

Study typeInterventional
Ages6 Years to 13 Years
SexAll
Enrollment20 (estimated)
SponsorEssilor International
Industry-sponsored
Locations1 site (Singapore)
StatusRecruiting
StartedAugust 13, 2026
Main results expectedNovember 2027
Study endsNovember 2027
Registry record updatedSeptember 15, 2026
Trial IDNCT07533149 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children 6–12 years old with anisometropic myopia (SER difference ≥1.0 D) and good visual acuity.

Probably not a fit

Children without anisometropia, with high corneal astigmatism, or with other ocular diseases may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study will enroll children aged 6 to under 13 with anisometropic myopia to wear specially designed study spectacles. Researchers will monitor changes in axial length and refractive error over time, using cycloplegic measurements to assess prescription accuracy. Participants will visit the Essilor R&D Centre and a clinical site for follow-up visits over a 12-month period. Data will help determine whether the spectacles can harmonize vision between eyes in this population.

Why it matters

Potential benefit: If successful, the intervention could reduce inter-eye refractive differences and stabilize eye growth in children with anisometropic myopia.

How similar studies have gone: Prior studies in myopia control have explored lenses and spectacles; this approach is a targeted, child-specific approach and its novelty/established success is evolving.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Voluntary
2. Informed consent of parent/guardian and assent of participant
3. Age equal to or greater than 6 years old and less than 13 years at the time of signing informed consent and assent
4. SER equal or less than -0.50 D and equal or greater than .5.00 D with astigmatism not more than 2.50 D
5. Difference in SER (anisometropia) between two eyes .1.00 D
6. Best corrected visual acuity (BCVA) better than or equal to +0.20 LogMAR in each eye
7. Agree to wear study spectacles for .12 hours/day and 7 days/week
8. Willingness and ability to participate in investigation for 12 months and attend scheduled visits punctually
9. Agree for no concurrent involvement in other myopia control treatment

Exclusion Criteria:

1. History or presence of an ocular disease affecting refractive status
2. History or presence of strabismus
3. Presence of amblyopia
4. Current or previous use of atropine and/or orthokeratology
5. Known allergy to cycloplegic agents
6. Contraindication to cycloplegic agents
7. Cognitive or psychological vulnerability

Where it's running

  • Essilor R&D Centre Singapore
    Singapore, Singapore
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.